StemBioSys -CELLvo™Cells / CELLvo™Matrix – Technical Bulletins


  • Optimized Isolation and Growth of Mesenchymal Stem Cells The CELLvo™ Matrix Advantage

    Human mesenchymal stem cells (hMSCs) are a promising tool for therapeutic applications in cell-based therapy and regenerative medicine. Although stem cells have emerged as the future of health care, there are still a number of unmet needs, which must be addressed before widespread clinical and therapeutic applications become a reality. One of the major challenges in cell therapy is obtaining sufficient numbers of quality stem cells. Stem cells are relatively rare, in the body, and have a tendency to lose their potency during in vitro expansion…

    Download the full document here.

  • Endothelial Progenitor Cells for Basic and Translational Research 

    CELLvo™ Human Cord Blood– Endothelial Progenitor Cells (hCB-EPCs)

    With superior colony forming ability, greater vessel formation, and greater
    angiogenic potential as compared to more common endothelial-type cells
    (hUVECs) – CELLvo™ hCB-EPCs are the cell of choice for researchers.
    • Highly proliferative
    • Greater intrinsic vessel formation capacity
    • Pro-angiogenic

    Download the full document here.